Lilly's Tirzepatide Shows Up Novo's Ozempic In Head-To-Head Diabetes Trial

 
• By Jessica Merrill
  
Competitive Advantage in a Business Competition Environment; 3d Render
Lilly sees a competitive advantage for tirzepatide • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category